Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Pancreatic Cancer: Timing, Treatments, and Management

Neuropathy is a common, dose-limiting toxicity of pancreatic cancer regimens (especially oxaliplatin (FOLFIRINOX), nab-paclitaxel (Abraxane), and sometimes gemcitabine).

Timing & Presentation

• Acute (Oxaliplatin): During/within hours of infusion. Cold-triggered paresthesias (mouth, throat, hands), dysphagia, laryngospasm. Transient (days).
• Chronic Cumulative (Oxaliplatin, Taxanes): Develops over cycles. Stocking-glove sensory loss (numbness, tingling, burning), proprioceptive loss (gait imbalance), fine motor impairment. Can progress months/years after treatment ends ("coasting").
• Autonomic: Orthostatic hypotension, GI dysmotility, urinary retention (less common).

Management Strategies

1. Dose Modification: Oncologist-led: reduce dose, increase interval, hold, or switch agent (e.g., drop oxaliplatin after 3-4 months → maintenance 5-FU/LV). Primary prevention.
2. Pharmacologic (Symptomatic):
   • Duloxetine (SNRI) — only agent with RCT evidence for CIPN pain (ASCO guideline).
   • Gabapentin / Pregabalin — widely used, modest evidence.
   • Tricyclics (nortriptyline) — effective but anticholinergic burden.
   • Topical: Lidocaine patches, compounded creams (ketamine/baclofen/amitriptyline).
3. Non-Pharmacologic:
   • Physical/Occupational Therapy: Balance, gait, fine motor training, desensitization, adaptive equipment.
   • Exercise: Aerobic + resistance (improves nerve blood flow, function).
   • Acupuncture: Some evidence for pain/QoL.
   • TENS: Variable response.
   • Cryotherapy (ice gloves/socks) during oxaliplatin infusion — may reduce acute/severe CIPN (mixed evidence).
4. Supplements (Discuss with Oncologist): Glutamine, Vitamin E, B-complex, Alpha-lipoic acid, Acetyl-L-carnitine — limited/conflicting data; avoid antioxidants during active chemo without approval.
5. Lifestyle: Avoid alcohol, smoking; optimize diabetes control; foot care (inspect daily, proper shoes) to prevent ulcers.

Key Principle

Early reporting of symptoms allows timely dose adjustment — the most effective way to prevent irreversible damage. Multidisciplinary care (oncology, neurology, PT/OT, pain, palliative) optimizes function and quality of life.